ATE385574T1 - Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen - Google Patents

Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen

Info

Publication number
ATE385574T1
ATE385574T1 AT03706157T AT03706157T ATE385574T1 AT E385574 T1 ATE385574 T1 AT E385574T1 AT 03706157 T AT03706157 T AT 03706157T AT 03706157 T AT03706157 T AT 03706157T AT E385574 T1 ATE385574 T1 AT E385574T1
Authority
AT
Austria
Prior art keywords
cell sample
melatonin
signaling pathway
idiopathic scoliosis
related diseases
Prior art date
Application number
AT03706157T
Other languages
English (en)
Inventor
Alain Moreau
Original Assignee
Chu Sainte Justine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chu Sainte Justine filed Critical Chu Sainte Justine
Application granted granted Critical
Publication of ATE385574T1 publication Critical patent/ATE385574T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Testing Of Engines (AREA)
  • Saccharide Compounds (AREA)
AT03706157T 2002-02-28 2003-02-28 Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen ATE385574T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002373854A CA2373854A1 (en) 2002-02-28 2002-02-28 Methods of diagnosing and counteracting adolescent idiopathic scoliosis

Publications (1)

Publication Number Publication Date
ATE385574T1 true ATE385574T1 (de) 2008-02-15

Family

ID=27762090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706157T ATE385574T1 (de) 2002-02-28 2003-02-28 Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen

Country Status (12)

Country Link
US (7) US20050130250A1 (de)
EP (1) EP1478928B1 (de)
AT (1) ATE385574T1 (de)
AU (1) AU2003208204A1 (de)
CA (1) CA2373854A1 (de)
CY (1) CY1107358T1 (de)
DE (1) DE60318987T2 (de)
DK (1) DK1478928T3 (de)
ES (1) ES2298498T3 (de)
HK (1) HK1071601A1 (de)
PT (1) PT1478928E (de)
WO (1) WO2003073102A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2373854A1 (en) 2002-02-28 2003-08-28 Alain Moreau Methods of diagnosing and counteracting adolescent idiopathic scoliosis
US20090104620A1 (en) * 2007-07-03 2009-04-23 Axial Biotech, Inc. Simplified Method of Determining Predisposition to Scoliosis
US20090035769A1 (en) * 2007-12-31 2009-02-05 Nelson Lesa M Genetic Markers Associated with Scoliosis and Uses Thereof
US20090035772A1 (en) * 2007-07-03 2009-02-05 Axial Biotech, Inc. Genetic Markers Associated With Scoliosis And Uses Thereof
US7655403B2 (en) * 2006-12-02 2010-02-02 Texas Scottish Rite Hospital For Children CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis
WO2008113174A1 (en) * 2007-03-19 2008-09-25 Chu Sainte-Justine Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same
KR101436578B1 (ko) 2007-03-30 2014-09-01 슈 생-쥐스땡 척추 측만증의 발병 위험성을 측정하는 방법, 척추 측만증에 걸린 대상자를 계층화하는 방법, 척추 측만증에 걸린 대상자에 있어서 고정기의 효능을 평가하는 방법, 및 이를 위한 키트
TWI443337B (zh) * 2008-10-10 2014-07-01 Ct Hospitalier Universitaire Sainte Justine 用於脊柱側彎之分類及診斷的方法
CA2808749C (en) * 2010-10-04 2019-06-11 Chu Sainte-Justine Biomechanical-based methods of diagnosing scoliosis
AU2014284078A1 (en) 2013-06-17 2016-01-07 Chu Sainte-Justine New markers for severe progression of idiopathic scoliosis and uses thereof to stratify scoliotic patients and predict the risk of developing scoliosis
AU2014284079B2 (en) 2013-06-17 2019-05-23 Chu Sainte-Justine A method of increasing GiPCR signalization in the cells of a scoliotic subject
CA2914208A1 (en) 2013-06-17 2014-12-24 Alain Moreau Gi protein phosphorylation as marker for scoliosis and scoliosis progression, methods of increasing gipcr signaling in scoliotic subjects
WO2015032004A1 (en) 2013-09-09 2015-03-12 Chu Sainte-Justine Method of treating and prognosing scoliotic patient subgroups
KR102397233B1 (ko) 2014-09-25 2022-05-12 프로제너티, 인크. 위치추정 능력을 갖는 전기기계 알약 장치
PL3310926T3 (pl) 2015-06-16 2019-11-29 Centro De Investig Biomedica En Red Ciber Sposób diagnozowania/oceny przypuszczalnego przebiegu młodzieńczej skoliozy idiopatycznej
CN109843182A (zh) * 2016-08-18 2019-06-04 普罗根尼蒂公司 使用可摄入装置获取样品的系统
KR102417504B1 (ko) 2016-09-09 2022-07-07 프로제너티, 인크. 분배가능한 물질의 전달을 위한 전자기계식 섭취가능한 디바이스
EP3551034A1 (de) 2016-12-07 2019-10-16 Progenity, Inc. Verfahren, vorrichtungen und systeme zur detektion des magen-darm-trakts
IL268900B2 (en) 2017-03-31 2023-11-01 Biora Therapeutics Inc Ingestion device placement systems and methods
CN113348011B (zh) 2018-11-19 2023-04-18 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
CN111575361A (zh) * 2020-04-20 2020-08-25 孙欣 一种褪黑素通路调控因子治疗ais患者的测试方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856124A (en) * 1994-06-17 1999-01-05 The General Hospital Corporation DNA encoding high-affinity melatonin receptors
DE69735852D1 (de) * 1996-07-18 2006-06-14 Gen Hospital Corp Regulatorische regionen des gens für den melatonin 1a rezeptor und deren verwendungen
JPH119282A (ja) * 1997-06-19 1999-01-19 Nippon Chem Res Kk メラトニン受容体発現細胞とその用途
WO2001009383A2 (en) * 1999-07-30 2001-02-08 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders
CA2373854A1 (en) * 2002-02-28 2003-08-28 Alain Moreau Methods of diagnosing and counteracting adolescent idiopathic scoliosis

Also Published As

Publication number Publication date
US20140113313A1 (en) 2014-04-24
WO2003073102A1 (en) 2003-09-04
PT1478928E (pt) 2008-04-09
US20050130250A1 (en) 2005-06-16
CA2373854A1 (en) 2003-08-28
US20120009600A1 (en) 2012-01-12
US7989175B2 (en) 2011-08-02
US8652791B2 (en) 2014-02-18
CY1107358T1 (el) 2012-12-19
EP1478928B1 (de) 2008-02-06
EP1478928A1 (de) 2004-11-24
AU2003208204A1 (en) 2003-09-09
HK1071601A1 (en) 2005-07-22
DE60318987T2 (de) 2009-01-29
DK1478928T3 (da) 2008-05-19
US20130115615A1 (en) 2013-05-09
ES2298498T3 (es) 2008-05-16
DE60318987D1 (de) 2008-03-20
US20160258947A1 (en) 2016-09-08
US20110256582A1 (en) 2011-10-20
US20090111110A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
ATE385574T1 (de) Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen
CY1109106T1 (el) Εγκαιρη διαγνωση ασθενειων διαταραχης διαμορφωσης πρωτεϊνων
DE60228557D1 (de) Candida-nachweis
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
EP2520935A3 (de) Organspezifische Proteine und Verfahren zu deren Verwendung
ATE394680T1 (de) Verfahren und vorrichtung zur charakterisierung von analyten
ATE461449T1 (de) Verfahren zum nachweis von medizinisch relevanten zuständen in gelösten lbc-proben
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
HK1088947A1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
ITRM20030386A0 (it) Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici.
WO2004057341A3 (en) Cvd assay
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
ATE520987T1 (de) Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum
EP2508886A3 (de) Mittel und Verfahren zur Klassifizierung von Proben von Multiple-Sklerose-Patienten.
ATE326982T1 (de) Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit copolymeren
ATE461452T1 (de) Verfahren zum nachweis von menschlichem parvovirus-antigen
ATE403739T1 (de) Verfahren zur verwendung teilungsarretierter zellen in screening-assays
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
SE0200974D0 (sv) Screening method for gastritis
DE602004022995D1 (de) Verfahren zur diagnose der immunität wiederkehrendren zur behandlung und überwachung
ATE550662T1 (de) Diagnose- und behandlungsverfahren sowie dafür geeignete mittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1478928

Country of ref document: EP

REN Ceased due to non-payment of the annual fee